| Survival Probability in % (95% Confidence Interval) | ||||||||||
| Test Population | White | Black | Other | Unkown | ||||||
| n | % | n | % | n | % | n | % | n | % | |
| 5-Year Survival | ||||||||||
| All Cases | 25 | 57.2% | 19 | 57.8% | 2 | 50.0% | 4 | 75.0% | 0 | -- |
| Age at diagnosis | ||||||||||
| 0 - 19 years | 13 | 74.6% | 8 | 87.5% | 2 | 50.0% | 3 | 66.7% | 0 | -- |
| 20 - 39 years | 5 | 25.9% | 5 | 25.9% | 0 | -- | 0 | -- | 0 | -- |
| 40 - 59 years | 5 | 66.7% | 4 | 66.7% | 0 | -- | 1 | -- | 0 | -- |
| >60 years | 2 | 0.0% | 2 | 0.0% | 0 | -- | 0 | -- | 0 | -- |
| Sex | ||||||||||
| Male | 14 | 58.5% | 12 | 54.8% | 1 | 100.0% | 1 | -- | 0 | -- |
| Female | 11 | 54.5% | 7 | 64.3% | 1 | 0.0% | 3 | 66.7% | 0 | -- |
| All phenotypes | ||||||||||
| T-cell | 4 | 50.0% | 3 | 33.3% | 0 | -- | 1 | 100.0% | 0 | -- |
| B-cell | 12 | 56.3% | 10 | 68.6% | 1 | 0.0% | 1 | 0.0% | 0 | -- |
| Unknown lineage | 4 | 75.0% | 3 | 66.7% | 1 | 100.0% | 0 | -- | 0 | -- |
| Other | 5 | 0.0% | 3 | 0.0% | 0 | -- | 2 | -- | 0 | -- |
| 10-Year Survival | ||||||||||
| All Cases | 25 | 46.8% | 19 | 51.4% | 2 | 50.0% | 4 | 0.0% | 0 | -- |
| Age at diagnosis | ||||||||||
| 0 - 19 years | 13 | 65.3% | 8 | 87.5% | 2 | 50.0% | 3 | 0.0% | 0 | -- |
| 20 - 39 years | 5 | 25.9% | 5 | 25.9% | 0 | -- | 0 | -- | 0 | -- |
| 40 - 59 years | 5 | 33.3% | 4 | 33.3% | 0 | -- | 1 | -- | 0 | -- |
| >60 years | 2 | 0.0% | 2 | 0.0% | 0 | -- | 0 | -- | 0 | -- |
| Sex | ||||||||||
| Male | 14 | 50.2% | 12 | 45.7% | 1 | 100.0% | 1 | -- | 0 | -- |
| Female | 11 | 40.9% | 7 | 64.3% | 1 | 0.0% | 3 | 0.0% | 0 | -- |
| All phenotypes | ||||||||||
| T-cell | 4 | 25.0% | 3 | 33.3% | 0 | -- | 1 | 0.0% | 0 | -- |
| B-cell | 12 | 46.9% | 10 | 57.1% | 1 | 0.0% | 1 | 0.0% | 0 | -- |
| Unknown lineage | 4 | 75.0% | 3 | 66.7% | 1 | 100.0% | 0 | -- | 0 | -- |
| Other | 5 | 0.0% | 3 | 0.0% | 0 | -- | 2 | -- | 0 | -- |